氨基酸(15)腹膜透析

Records for this ingredient, by country (identity only).

ATC B05BA · 1 markets · 4 records

氨基酸(15)腹膜透析 1 markets · 4 records Forms
Filters
MarketCN 4

CN 4 records · 3 shown of 3 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 2,000 mL per mL / per unit basis not statedinjectionManufacturer: 成都青山利康药业股份有限公司 ×2Manufacturer: 津药和平(天津)制药有限公司
  • 2,500 mL per mL / per unit basis not statedinjectionManufacturer: 成都青山利康药业股份有限公司 ×2
  • 22,410 mg/2,000 mLinjectionManufacturer: 山东威高药业股份有限公司

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.